{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:40:10Z","timestamp":1791272410362,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/nrc3459","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T10:16:29Z","timestamp":1360836989000},"page":"153-159","source":"Crossref","is-referenced-by-count":587,"title":["BAP1 and cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Michele","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"BFnrc3459_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2068","volume":"7","author":"M Carbone","year":"2007","unstructured":"Carbone, M. et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nature Rev. Cancer 7, 147\u2013154 (2007).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc3459_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","volume":"18","author":"M Carbone","year":"2012","unstructured":"Carbone, M. & Yang, H. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin. Cancer Res. 18, 598\u2013604 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc3459_CR3","doi-asserted-by":"publisher","first-page":"13618","DOI":"10.1073\/pnas.1105887108","volume":"108","author":"M Carbone","year":"2011","unstructured":"Carbone, M. et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc. Natl Acad. Sci. USA 108, 13618\u201313623 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3459_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","volume":"357","author":"I Roushdy-Hammady","year":"2001","unstructured":"Roushdy-Hammady, I., Siegel, J., Emri, S., Testa, J. R. & Carbone, M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357, 444\u2013445 (2001).","journal-title":"Lancet"},{"key":"BFnrc3459_CR5","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1158\/0008-5472.CAN-05-4642","volume":"66","author":"AU Dogan","year":"2006","unstructured":"Dogan, A. U. et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res. 66, 5063\u20135068 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc3459_CR6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa, J. R. et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genet. 43, 1022\u20131025 (2011).","journal-title":"Nature Genet."},{"key":"BFnrc3459_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413 (2010).","journal-title":"Science"},{"key":"BFnrc3459_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/gcc.2870090114","volume":"9","author":"YY Lu","year":"1994","unstructured":"Lu, Y. Y., Jhanwar, S. C., Cheng, J. Q. & Testa, J. R. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer 9, 76\u201380 (1994).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc3459_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/gcc.2870110104","volume":"11","author":"MA Zeiger","year":"1994","unstructured":"Zeiger, M. A., Gnarra, J. R., Zbar, B., Linehan, W. M. & Pass, H. I. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chromosomes Cancer 11, 15\u201320 (1994).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc3459_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner, T. et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nature Genet. 43, 1018\u20131021 (2011).","journal-title":"Nature Genet."},{"key":"BFnrc3459_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","volume":"36","author":"T Wiesner","year":"2012","unstructured":"Wiesner, T. et al. A distinct subset of atypical spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am. J. Surg. Pathol. 36, 818\u2013830 (2012).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrc3459_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"1066","author":"M Carbone","year":"2012","unstructured":"Carbone, M. et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J. Transl. Med. 1066, 179 (2012).","journal-title":"J. Transl. Med."},{"key":"BFnrc3459_CR13","doi-asserted-by":"publisher","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","volume":"766","author":"CN Njauw","year":"2012","unstructured":"Njauw, C. N. et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS ONE 766, e35295 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrc3459_CR14","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","volume":"30","author":"T Wiesner","year":"2012","unstructured":"Wiesner, T. et al. Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations. J. Clin. Oncol. 30, e337\u2013e340 (2012).","journal-title":"J. Clin. Oncol."},{"key":"BFnrc3459_CR15","first-page":"407","volume":"161","author":"B Cagianut","year":"1972","unstructured":"Cagianut, B. Melanoma of the choroid and ciliary body, malignant meningioma and mesothelioma of the pleura (triple-malignoma) in a 63-year old female. Klin. Monbl. Augenheilkd. 161, 407\u2013411 (1972).","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"BFnrc3459_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman, M. H. et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J. Med. Genet. 48, 856\u2013859 (2011).","journal-title":"J. Med. Genet."},{"key":"BFnrc3459_CR17","unstructured":"Aoude, L. G., Vajdic, C. M., Kricker, A., Armstrong, B. & Hayward, N. K. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases. Pigment Cell Melanoma Res. 11 Dec 2012 (doi:10.1111\/pcmr.12046)."},{"key":"BFnrc3459_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nature Genet. 44, 751\u2013759 (2012).","journal-title":"Nature Genet."},{"key":"BFnrc3459_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/pcmr.12006","volume":"25","author":"K Wadt","year":"2012","unstructured":"Wadt, K. et al. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res. 25, 815\u2013818 (2012).","journal-title":"Pigment Cell Melanoma Res."},{"key":"BFnrc3459_CR20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/jnci\/dji312","volume":"97","author":"CB Begg","year":"2005","unstructured":"Begg, C. B. et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J. Natl Cancer Inst. 97, 1507\u20131515 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc3459_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li, F. P. & Fraumeni, J. F. Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med. 71, 747\u2013752 (1969).","journal-title":"Ann. Intern. Med."},{"key":"BFnrc3459_CR22","doi-asserted-by":"publisher","first-page":"e6764","DOI":"10.1371\/journal.pone.0006764","volume":"466","author":"A Bheda","year":"2009","unstructured":"Bheda, A., Shackelford, J. & Pagano, J. S. Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes. PLoS ONE 466, e6764 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrc3459_CR23","first-page":"1","volume":"1806","author":"Y Fang","year":"2010","unstructured":"Fang, Y., Fu, D. & Shen, X. Z. The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Biochim. Biophys. Acta 1806, 1\u20136 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrc3459_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen, D. E. et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097\u20131112 (1998).","journal-title":"Oncogene"},{"key":"BFnrc3459_CR25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott, M. et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nature Genet. 43, 668\u2013672 (2011).","journal-title":"Nature Genet."},{"key":"BFnrc3459_CR26","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.1093\/emboj\/cdf691","volume":"21","author":"DL Mallery","year":"2002","unstructured":"Mallery, D. L., Vandenberg, C. J. & Hiom, K. Activation of the E3 ligase function of the BRCA1\/BARD1 complex by polyubiquitin chains. EMBO J. 21, 6755\u20136762 (2002).","journal-title":"EMBO J."},{"key":"BFnrc3459_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.1381306","volume":"20","author":"RA Greenberg","year":"2006","unstructured":"Greenberg, R. A. et al. Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes. Genes Dev. 20, 34\u201346 (2006).","journal-title":"Genes Dev."},{"key":"BFnrc3459_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","volume":"69","author":"H Nishikawa","year":"2009","unstructured":"Nishikawa, H. et al. BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity. Cancer Res. 69, 111\u2013119 (2009).","journal-title":"Cancer Res."},{"key":"BFnrc3459_CR29","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","volume":"68","author":"KH Ventii","year":"2008","unstructured":"Ventii, K. H. et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 68, 6953\u20136962 (2008).","journal-title":"Cancer Res."},{"key":"BFnrc3459_CR30","doi-asserted-by":"publisher","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","volume":"284","author":"YJ Machida","year":"2009","unstructured":"Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A. & Dutta, A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J. Biol. Chem. 284, 34179\u201334188 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrc3459_CR31","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/MCB.01517-08","volume":"29","author":"S Misaghi","year":"2009","unstructured":"Misaghi, S. et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol. Cell. Biol. 29, 2181\u20132192 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc3459_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molcel.2007.05.030","volume":"27","author":"S Tyagi","year":"2007","unstructured":"Tyagi, S., Chabes, A. L., Wysocka, J. & Herr, W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell 27, 107\u2013119 (2007).","journal-title":"Mol. Cell"},{"key":"BFnrc3459_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12013-011-9184-6","volume":"60","author":"ZM Eletr","year":"2011","unstructured":"Eletr, Z. M. & Wilkinson, K. D. An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem. Biophys. 60, 3\u201311 (2011).","journal-title":"Cell Biochem. Biophys."},{"key":"BFnrc3459_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","volume":"465","author":"JC Scheuermann","year":"2010","unstructured":"Scheuermann, J. C. et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465, 243\u2013247 (2010).","journal-title":"Nature"},{"key":"BFnrc3459_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrm2763","volume":"10","author":"JA Simon","year":"2009","unstructured":"Simon, J. A. & Kingston, R. E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nature Rev. Mol. Cell Biol. 10, 697\u2013708 (2009).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrc3459_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1242\/dev.074450","volume":"139","author":"L Gutierrez","year":"2012","unstructured":"Gutierrez, L. et al. The role of the histone H2A ubiquitinase Sce in Polycomb repression. Development 139, 117\u2013127 (2012).","journal-title":"Development"},{"key":"BFnrc3459_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10371","volume":"477","author":"Q Zhu","year":"2011","unstructured":"Zhu, Q. et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477, 179\u2013184 (2011).","journal-title":"Nature"},{"key":"BFnrc3459_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","volume":"18","author":"CD Kemp","year":"2012","unstructured":"Kemp, C. D. et al. Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin. Cancer Res. 18, 77\u201390 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc3459_CR39","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1128\/MCB.00396-10","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu, H. et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol. Cell. Biol. 30, 5071\u20135085 (2010).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc3459_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1169727","volume":"325","author":"MC Gambetta","year":"2009","unstructured":"Gambetta, M. C., Oktaba, K. & Muller, J. Essential role of the glycosyltransferase sxc\/Ogt in polycomb repression. Science 325, 93\u201396 (2009).","journal-title":"Science"},{"key":"BFnrc3459_CR41","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey, A. et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337, 1541\u20131546 (2012).","journal-title":"Science"},{"key":"BFnrc3459_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cmet.2012.07.006","volume":"16","author":"HB Ruan","year":"2012","unstructured":"Ruan, H. B. et al. O-GlcNAc transferase\/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1\u03b1 stability. Cell Metab. 16, 226\u2013237 (2012).","journal-title":"Cell Metab."},{"key":"BFnrc3459_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","volume":"103","author":"Y Yoshikawa","year":"2012","unstructured":"Yoshikawa, Y. et al. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci. 103, 868\u2013874 (2012).","journal-title":"Cancer Sci."},{"key":"BFnrc3459_CR44","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","volume":"72","author":"S Jube","year":"2012","unstructured":"Jube, S. et al. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 72, 3290\u20133301 (2012).","journal-title":"Cancer Res"},{"key":"BFnrc3459_CR45","doi-asserted-by":"publisher","first-page":"e1001086","DOI":"10.1371\/journal.pbio.1001086","volume":"966","author":"B Celona","year":"2011","unstructured":"Celona, B. et al. Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. 966, e1001086 (2011).","journal-title":"PLoS Biol."},{"key":"BFnrc3459_CR46","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/jnci\/86.19.1476","volume":"86","author":"EP Horn","year":"1994","unstructured":"Horn, E. P., Hartge, P., Shields, J. A. & Tucker, M. A. Sunlight and risk of uveal melanoma. J. Natl Cancer Inst. 86, 1476\u20131478 (1994).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc3459_CR47","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1073\/pnas.0707579104","volume":"104","author":"MP Stokes","year":"2007","unstructured":"Stokes, M. P. et al. Profiling of UV-induced ATM\/ATR signaling pathways. Proc. Natl Acad. Sci. USA 104, 19855\u201319860 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3459_CR48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville, S. et al. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin. Cancer Res. 18, 408\u2013416 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc3459_CR49","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","volume":"135","author":"RM Flores","year":"2008","unstructured":"Flores, R. M. et al. Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J. Thorac. Cardiovasc. Surg. 135, 620\u2013626.e3 (2008).","journal-title":"J. Thorac. Cardiovasc. Surg."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc3459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc3459","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc3459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:35:51Z","timestamp":1684467351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc3459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFnrc3459"],"URL":"https:\/\/doi.org\/10.1038\/nrc3459","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}